Brief: Dawnrays Pharmaceutical Holdings Posts FY Profit Attributable RMB304 Mln
21/03/2019 10:23
March 21 (Reuters) - Dawnrays Pharmaceutical Holdings Ltd
2348.HK :
* FY PROFIT ATTRIBUTABLE RMB304 MILLION VERSUS RMB293
MILLION
* FY REVENUE RMB 948.9MLN, UP 7.5 PERCENT
* PROPOSED FINAL DIVIDEND PER SHARE HK$ 0.06
Source text for Eikon: ID:nHKS8BGZKb
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO